Annual Current Assets
$50.44 M
-$17.71 M-25.98%
30 April 2024
Summary:
PharmaCyte Biotech annual total current assets is currently $50.44 million, with the most recent change of -$17.71 million (-25.98%) on 30 April 2024. During the last 3 years, it has risen by +$48.16 million (+2116.94%). PMCB annual current assets is now -41.00% below its all-time high of $85.49 million, reached on 30 April 2022.PMCB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$32.88 M
-$17.56 M-34.82%
31 July 2024
Summary:
PharmaCyte Biotech quarterly total current assets is currently $32.88 million, with the most recent change of -$17.56 million (-34.82%) on 31 July 2024. Over the past year, it has dropped by -$40.87 million (-55.42%). PMCB quarterly current assets is now -62.29% below its all-time high of $87.18 million, reached on 31 October 2021.PMCB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.0% | -55.4% |
| 3 y3 years | +2116.9% | -62.3% |
| 5 y5 years | +7619.6% | +10000.0% |
PMCB Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.0% | +2116.9% | -62.3% | at low |
| 5 y | 5 years | -41.0% | +7619.6% | -62.3% | >+9999.0% |
| alltime | all time | -41.0% | -62.3% |
PharmaCyte Biotech Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $32.88 M(-34.8%) |
| Apr 2024 | $9.46 M(+84.5%) | $50.44 M(-18.0%) |
| Jan 2024 | - | $61.51 M(-16.6%) |
| Oct 2023 | - | $73.75 M(-1.3%) |
| July 2023 | - | $74.75 M(+9.7%) |
| Apr 2023 | $5.13 M(0.0%) | $68.15 M(-6.4%) |
| Jan 2023 | - | $72.82 M(-5.7%) |
| Oct 2022 | - | $77.22 M(-6.1%) |
| July 2022 | - | $82.26 M(-3.8%) |
| Apr 2022 | $5.13 M(+0.0%) | $85.49 M(-1.5%) |
| Jan 2022 | - | $86.81 M(-0.4%) |
| Oct 2021 | - | $87.18 M(+5679.7%) |
| July 2021 | - | $1.51 M(-33.7%) |
| Apr 2021 | $5.13 M(0.0%) | $2.28 M(-27.4%) |
| Jan 2021 | - | $3.13 M(-17.8%) |
| Oct 2020 | - | $3.81 M(+65.5%) |
| July 2020 | - | $2.30 M(+122.0%) |
| Apr 2020 | $5.13 M(0.0%) | $1.04 M(+396.0%) |
| Jan 2020 | - | $209.20 K(-0.0%) |
| Oct 2019 | - | $209.30 K(-56.1%) |
| July 2019 | - | $477.00 K(-27.0%) |
| Apr 2019 | $5.13 M(0.0%) | $653.40 K(-7.7%) |
| Jan 2019 | - | $707.90 K(-24.5%) |
| Oct 2018 | - | $937.60 K(-52.0%) |
| July 2018 | - | $1.95 M(+52.0%) |
| Apr 2018 | $5.13 M(0.0%) | $1.28 M(-19.6%) |
| Jan 2018 | - | $1.60 M(-42.7%) |
| Oct 2017 | - | $2.79 M(-36.6%) |
| July 2017 | - | $4.40 M(+24.2%) |
| Apr 2017 | $5.13 M(-0.0%) | $3.54 M(+42.3%) |
| Jan 2017 | - | $2.49 M(+55.1%) |
| Oct 2016 | - | $1.60 M(-33.1%) |
| July 2016 | - | $2.39 M(+17.9%) |
| Apr 2016 | $5.13 M(0.0%) | $2.03 M(-29.3%) |
| Jan 2016 | - | $2.87 M(+14.3%) |
| Oct 2015 | - | $2.51 M(-16.6%) |
| July 2015 | - | $3.01 M(-27.7%) |
| Apr 2015 | $5.13 M(0.0%) | $4.17 M(+318.1%) |
| Jan 2015 | - | $997.00 K(-22.1%) |
| Oct 2014 | - | $1.28 M(-58.3%) |
| July 2014 | - | $3.07 M(-26.7%) |
| Apr 2014 | $5.13 M | $4.19 M(+171.7%) |
| Jan 2014 | - | $1.54 M(+226.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2013 | - | $472.60 K(-73.8%) |
| July 2013 | - | $1.80 M(-2.4%) |
| Apr 2013 | $1.03 M(0.0%) | $1.85 M(+30.0%) |
| Jan 2013 | - | $1.42 M(+10.5%) |
| Oct 2012 | - | $1.29 M(+6.8%) |
| July 2012 | - | $1.21 M(+13.9%) |
| Apr 2012 | $1.03 M(-9.4%) | $1.06 M(+40.8%) |
| Jan 2012 | - | $751.90 K(+24.0%) |
| Oct 2011 | - | $606.50 K(+35.0%) |
| July 2011 | - | $449.20 K(+329.0%) |
| Apr 2011 | $1.14 M(-4.5%) | $104.70 K(+200.9%) |
| Jan 2011 | - | $34.80 K(+167.7%) |
| Oct 2010 | - | $13.00 K(+88.4%) |
| July 2010 | - | $6900.00(-49.6%) |
| Apr 2010 | $1.19 M(-75.5%) | $13.70 K(-92.9%) |
| Jan 2010 | - | $191.90 K(-45.0%) |
| Oct 2009 | - | $349.20 K(-15.7%) |
| July 2009 | - | $414.20 K(-65.0%) |
| Apr 2009 | $4.86 M(+25.1%) | $1.18 M(-49.9%) |
| Jan 2009 | - | $2.36 M(-18.3%) |
| Oct 2008 | - | $2.89 M(-14.4%) |
| July 2008 | - | $3.37 M(-9.7%) |
| Apr 2008 | $3.88 M(+299.3%) | $3.74 M(+8.2%) |
| Jan 2008 | - | $3.45 M(+50.7%) |
| Oct 2007 | - | $2.29 M(-23.6%) |
| July 2007 | - | $3.00 M(-12.6%) |
| Apr 2007 | $971.90 K(-51.6%) | $3.43 M(+18.6%) |
| Jan 2007 | - | $2.90 M(+31.6%) |
| Oct 2006 | - | $2.20 M(-13.4%) |
| July 2006 | - | $2.54 M(-18.8%) |
| Apr 2006 | $2.01 M(+1522.3%) | $3.13 M(+718.0%) |
| Jan 2006 | - | $382.50 K(+199.3%) |
| Oct 2005 | - | $127.80 K(+85.8%) |
| July 2005 | - | $68.80 K(-67.7%) |
| Apr 2005 | $123.70 K(+174.9%) | $212.70 K(-73.4%) |
| Jan 2005 | - | $798.30 K(-33.8%) |
| Oct 2004 | - | $1.21 M(-50.0%) |
| July 2004 | - | $2.41 M(+1746.4%) |
| Apr 2004 | $45.00 K | $130.70 K(+142.5%) |
| Jan 2004 | - | $53.90 K(>+9900.0%) |
| Oct 2003 | - | $0.00(0.0%) |
| July 2003 | - | $0.00(0.0%) |
| Apr 2003 | - | $0.00 |
FAQ
- What is PharmaCyte Biotech annual total current assets?
- What is the all time high annual current assets for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual current assets year-on-year change?
- What is PharmaCyte Biotech quarterly total current assets?
- What is the all time high quarterly current assets for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly current assets year-on-year change?
What is PharmaCyte Biotech annual total current assets?
The current annual current assets of PMCB is $50.44 M
What is the all time high annual current assets for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual total current assets is $85.49 M
What is PharmaCyte Biotech annual current assets year-on-year change?
Over the past year, PMCB annual total current assets has changed by -$17.71 M (-25.98%)
What is PharmaCyte Biotech quarterly total current assets?
The current quarterly current assets of PMCB is $32.88 M
What is the all time high quarterly current assets for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly total current assets is $87.18 M
What is PharmaCyte Biotech quarterly current assets year-on-year change?
Over the past year, PMCB quarterly total current assets has changed by -$40.87 M (-55.42%)